Fidelity Select Pharmaceuticals Portfolio
FPHAX
NASDAQ
| Weiss Ratings | FPHAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Reward Grade | B | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Company Info | FPHAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Fidelity Investments | |||
| Manager/Tenure (Years) | Karim Suwwan de Felipe (9) | |||
| Website | http://www.institutional.fidelity.com | |||
| Fund Information | FPHAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Fidelity Select Pharmaceuticals Portfolio | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Jun 18, 2001 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 0.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | FPHAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 2.55% | |||
| Dividend | FPHAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.47% | |||
| Asset Allocation | FPHAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 1.05% | |||
| Stock | 98.44% | |||
| U.S. Stock | 74.17% | |||
| Non-U.S. Stock | 24.27% | |||
| Bond | 0.08% | |||
| U.S. Bond | 0.08% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.43% | |||
| Price History | FPHAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 6.18% | |||
| 30-Day Total Return | 11.03% | |||
| 60-Day Total Return | 8.84% | |||
| 90-Day Total Return | 13.07% | |||
| Year to Date Total Return | 26.51% | |||
| 1-Year Total Return | 37.09% | |||
| 2-Year Total Return | 50.10% | |||
| 3-Year Total Return | 100.95% | |||
| 5-Year Total Return | 103.75% | |||
| Price | FPHAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | FPHAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | -- | |||
| 1-Month Low NAV | $33.55 | |||
| 1-Month High NAV | $37.58 | |||
| 52-Week Low NAV | $29.05 | |||
| 52-Week Low NAV (Date) | Nov 04, 2025 | |||
| 52-Week High NAV | $37.58 | |||
| 52-Week High Price (Date) | Oct 29, 2026 | |||
| Beta / Standard Deviation | FPHAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.62 | |||
| Standard Deviation | 17.98 | |||
| Balance Sheet | FPHAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 1.61B | |||
| Operating Ratios | FPHAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.67% | |||
| Turnover Ratio | 77.00% | |||
| Performance | FPHAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 37.68% | |||
| Last Bear Market Total Return | -2.37% | |||